Infectious diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The subjects of this retrospective study were next-generation sequencing (NGS) of pathogenic microorganisms from December 1, 2021 to December 1, 2026 in Shenzhen Hospital of the University of Hong Kong. No less than 1200 cases are expected to be collected according to the number of NGS tests submitted monthly and the statistical time.
Exclusion criteria
Exclusion criteria: Exclusion criteria should not be the reverse range of inclusion criteria, please fill in again.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sex;age;chief complaint;liver function;renal function;prothrombin time;activated partial thromboplastin time;blood culture;sputum culture;urine culture;sterile body fluid culture;bronchoalveolar lavage fluid culture;bronchoalveolar lavage fluid for PJP smear;anti-fast bacillus smear;Tuberculosis DNA;Herpes simplex virus DNA;Varicella zoster virus DNA;C-reaction protein;procaicltonin;beta-D-glucan;aspergillus antigen;crypotococcal antigen;chest X-ray;brain computerized tomography;thoracic computerized tomography;abdominal computerized tomography;brain magnetic resonance imaging;sterile body fluid analysis;pleural adenosine deaminase;High-throughput sequencing of pathogenic microorganisms;clinical diagnosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| underlying diseases; | — |
Countries
China
Contacts
The University of Hong Kong-Shenzhen Hospital